Feasibility of targeted radiotherapy dose escalation in neoadjuvant treatment of locally advanced rectal adenocarcinoma using diffusion-weighted magnetic resonance imaging
University of the Sunshine Coast · 01.01.2025
DOI: 10.25907/00935 ↗Kurz gefasst
Fachartikel in der Zeitschrift University of the Sunshine Coast, erschienen am 01.01.2025. Verfasst von Nathan Hearn.
Abstract (Originalsprache)
Treatment of locally advanced rectal cancer (LARC) is progressing to one of watchful waiting in patients with complete response to neoadjuvant chemoradiotherapy (nCRT) in order to avoid the significant long-term quality of life impacts following surgery with colostomy formation. Dose escalated radiotherapy may improve locoregional disease control, including rates of pathological and clinical complete response (pCR and cCR); however, conformal and targeted techniques are required to achieve this while minimising treatment-related toxicity.
Schlagwörter
Zitieren
APA
Hearn, N. (2025). Feasibility of targeted radiotherapy dose escalation in neoadjuvant treatment of locally advanced rectal adenocarcinoma using diffusion-weighted magnetic resonance imaging. University of the Sunshine Coast. https://doi.org/10.25907/00935
Vancouver
Hearn N. Feasibility of targeted radiotherapy dose escalation in neoadjuvant treatment of locally advanced rectal adenocarcinoma using diffusion-weighted magnetic resonance imaging. University of the Sunshine Coast. 2025. doi:10.25907/00935
BibTeX
@article{Hearn2025,
author = {Hearn, Nathan},
title = {Feasibility of targeted radiotherapy dose escalation in neoadjuvant treatment of locally advanced rectal adenocarcinoma using diffusion-weighted magnetic resonance imaging},
journal = {University of the Sunshine Coast},
year = {2025},
doi = {10.25907/00935}
}
EUVIMED